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345 Abstract
46 Accumulating evidence suggests that changes in the metabolic signature of microglia 
47 underlie their response to inflammation. We sought to increase our knowledge of how 
48 pro-inflammatory stimuli induce metabolic changes. Primary microglia exposed to LPS 
49 expressed excessive fission leading to more fragmented mitochondria than tubular 
50 mitochondria. LPS mediated TLR4 activation also resulted in metabolic reprogramming 
51 from oxidative phosphorylation to glycolysis. Blockade of mitochondrial fission by Mdivi-
52 1, a putative mitochondrial division inhibitor led to the reversal of the metabolic shift. Mdivi-
53 1 treatment also normalized the changes caused by LPS exposure, namely an increase 
54 in mitochondrial ROS production and mitochondrial membrane potential as well as 
55 accumulation of key metabolic intermediate of TCA cycle succinate. Moreover, Mdvi-1 
56 treatment substantially reduced LPS induced cytokine and chemokine production. Finally, 
57 we showed that Mdivi-1 treatment attenuated expression of genes related to cytotoxic, 
58 repair and immunomodulatory microglia phenotypes in an in vivo neuroinflammation 
59 paradigm. Collectively, our data show that the activation of microglia to a classically pro-
60 inflammatory state associated with a switch to glycolysis that is mediated by mitochondrial 
61 fission, a process which may be a pharmacological target for immunomodulation.
62 Key words: inflammation, mitochondria, microglia, metabolism, mitochondrial fission
63 Main points:
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464 LPS induces mitochondrial fragmentation and a metabolic switch in microglia.
65 Blockade of fragmentation by Mdivi-1 reverses the metabolic shift, enhanced cytokine 
66 production, succinate accumulation in vitro and microglial activation in vivo. 
Page 4 of 54
John Wiley & Sons, Inc.
GLIA
567 Introduction
68 Microglia contribute to normal brain development, homeostasis and respond to 
69 pathological conditions by changing their phenotype from surveillance to pro-
70 inflammatory, repair, regenerative and immunomodulatory states (Greter, Lelios, & 
71 Croxford, 2015; Tay, Savage, Hui, Bisht, & Tremblay, 2017). Studies of adult and 
72 neonatal injury and disease have conclusively shown that changes in the phenotype of 
73 microglia play a role in almost all forms of neuropathology (Solito & Sastre, 2012). 
74 Transcriptome analysis of microglia exposed to inflammatory stimuli revealed transient 
75 upregulation of important and stimulus-specific metabolic pathways (Thion et al., 2018), 
76 strongly suggesting that energy metabolism is modulated during brain inflammation. 
77 Microglia activation in response to stimuli that includes pathogen associated proteins, 
78 such as lipopolysaccharide (LPS), is a metabolically energy expensive event (Moss & 
79 Bates, 2001). 
80 Mitochondria, which play a central role in energy metabolism, are dynamic organelles that 
81 undergo biogenesis, fission, fusion and mitophagy (autophagic degradation). The 
82 balance of these processes allows the reorganization of mitochondrial components and 
83 the elimination of damaged material, thereby maintaining a healthy mitochondrial 
84 population (Pickles, Vigie, & Youle, 2018; Wai & Langer, 2016) .  Recent studies have 
85 linked mitochondrial dynamics to energy demand, suggesting changes in mitochondrial 
86 architecture as a mechanism for bioenergetic adaptation to inflammation (Nasrallah & 
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687 Horvath, 2014). By favoring either elongated or fragmented structures, mitochondria can 
88 regulate bioenergetic ability and thereby cell fate through metabolic programming (Buck 
89 et al., 2016). Although mitochondrial morphological changes are observed in response to 
90 alterations in oxidative metabolism (Hackenbrock, 1966), little is known of its role in 
91 microglia activation. 
92 Microglia generate energy via both oxidative phosphorylation (OXPHOS) and glycolysis 
93 (Orihuela, McPherson, & Harry, 2016). OXPHOS occurs within the mitochondria and is 
94 more efficient for ATP synthesis in comparison to glycolysis. However, the preferential 
95 use of glycolysis over OXPHOS for ATP production enables activated microglia to 
96 produce ATP at a faster rate (Schuster, Boley, Moller, Stark, & Kaleta, 2015). Enhanced 
97 glycolysis supplies biosynthetic intermediates for cell growth and rapid production 
98 intermediates for cytokine production such as reactive oxygen species (ROS) thereby 
99 enabling effector functions (Chang et al., 2013; Everts et al., 2014). In macrophages or 
100 dendritic cells, pro-inflammatory stimuli cause them to undergo a metabolic switch from 
101 OXPHOS to glycolysis, a phenomenon similar to the Warburg effect (Kelly & O'Neill, 
102 2015). Microglia share many functions and characteristics with macrophages (Butovsky 
103 & Weiner, 2018) but they are from a distinct non-hematopoietic lineage, and whether a 
104 similar switch from OXPHOS to glycolysis has not been explored in microglia. 
105 We have previously found that both Toll-like receptor (TLR)-induced inflammation and 
106 mitochondrial dysfunction are involved in the development of neonatal brain injury 
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7107 (Hagberg, Mallard, Rousset, & Thornton, 2014; Mottahedin et al., 2017). We have also 
108 found that mitochondrial ROS production and inflammation is increased after neonatal 
109 brain injury associated with altered Krebs cycle and succinate accumulation in the 
110 mitochondria (Koning et al., 2017). Activation of microglia results in an altered Krebs 
111 cycle, as a result of metabolic switch promoting inflammatory gene expression (Gimeno-
112 Bayon, Lopez-Lopez, Rodriguez, & Mahy, 2014; Leaw et al., 2017; Orihuela et al., 2016). 
113 Katoh et al.  found that that mitochondrial fission via the activation of DRP1 (by TLR4 
114 stimulation) increases mitochondrial fission but they did not look in to metabolism or 
115 cytokine production in microglia (Katoh et al., 2017). Here, we add data on how TLR4 
116 activation affects mitochondrial morphology, energy metabolism, ROS and cytokine 
117 production in microglia. This knowledge is important given the many roles of microglia in 
118 mediating host-defenses, and how these processes can mediate injury to the brain when 
119 activation is aberrant and prolonged. ROS signaling has been demonstrated to result in 
120 damage to cell components; at the same time ROS production is essential for host 
121 defenses (Y. Zhang et al., 2012). 
122 In this study, we investigated the link between mitochondrial architecture and metabolic 
123 reprogramming in primary microglia after induction to a prototypical pro-inflammatory 
124 activation state via LPS-mediated TLR4 activation. We also used the putative 
125 mitochondrial fission inhibitor, Mdivi-1 (Cassidy-Stone et al., 2008) to modulate 
126 mitochondrial dynamics in vitro and in vivo. We found that pro-inflammatory activation of 
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8127 microglia changes the mitochondrial dynamics including a metabolic switch from 
128 OXPHOS to glycolysis and that Mdivi-1 reverses these effects and the expected LPS-
129 induced cytokine production and ROS production in vitro.  Further, we investigated the 
130 effect of Mdivi-1 in an in vivo paradigm of neuroinflammation and found that Mdivi-1 
131 reduced the expression of genes related to cytotoxic, repair and immunomodulatory 
132 microglia phenotypes. 
133 Materials and Methods
134 Animals of in vitro experiments
135 Pregnant C57BL/6 mice were sourced from Charles River Laboratories International 
136 (Sulzfeld, Germany). C57BL/6J-Tg(CAG-Cox8/EGFP)49Rin mice (Cox8/EGFP; 
137 RBRC02250)  expressing endogenous green florescent protein in cytochrome c oxidase, 
138 subunit VIIIa of mitochondria (Shitara et al., 2001) were obtained from Riken bio resource 
139 center, Japan.  Animals were housed and bred at the Experimental Biomedicine animal 
140 facility (University of Gothenburg, Gothenburg, Sweden) under specific pathogen free 
141 conditions on a 12 h light/dark 7 cycle with ad libitum access to standard laboratory chow 
142 (B&K, Solna, Sweden) and water. All experiments were approved by the local ethical 
143 committee at University of Gothenburg (No: 203-2014 and 32-2016) and performed 
144 according to the Guidelines for the care and use of Laboratory Animals.
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146 Primary cultures of purified microglia were created from 1 to 3-day-old C57BL/6 or 
147 Cox8/EGFP mice of both sexes, as previously described (Dean et al., 2010) with minor 
148 adaptations. Following decapitation, the brain was isolated with the meninges removed 
149 and washed in ice-cold Hanks buffered salt solution (HBSS; Sigma–Aldrich, St Louis, MO, 
150 USA) supplemented with 100 U/mL penicillin and 100 µg/mL streptomycin (Sigma–
151 Aldrich). Forebrains were dissociated by gentle trituration in Dulbecco’s modified Eagle’s 
152 medium (DMEM; Sigma–Aldrich) supplemented with 20% heat-inactivated fetal bovine 
153 serum (FBS; Fischer Scientific, Goteborg, Sweden) and antibiotics. The cell suspension 
154 was passed through a 70 µm cell sieve (Falcon, Corning, USA), plated in 75-cm2 flasks 
155 with vented caps (Sarstedt, Germany) at a density of two brains/flask, and cultured 
156 undisturbed for seven days with HBSS/20% FBS/antibiotics. Medium was then replaced 
157 with HBSS/10% FBS/antibiotics, and cells were cultured for a further seven days. 
158 Microglia were selectively detached from the flasks by shaking (3 h, 370C, 250 rpm) on a 
159 rotary shaker and the microglia cell suspension was collected and centrifuged (250 g × 
160 10 min). The media were then removed, the pellet was suspended in DMEM/2% 
161 FBS/antibiotics and the number of cells were counted with an automated cell counter 
162 (Scepter; Millipore) and seeded into Seahorse XFe96 or 24 cell well plates (1× 105 cells 
163 per well). The purity of microglia cells was evaluated by immunocytochemical staining 
164 using antibodies against ionized calcium binding adapter molecule 1 (Iba1; 1:1000; Wako 
165 Pure Chemical Industries, Ltd., Richmond, VA, USA) and DAPI (1:1000; Sigma–Aldrich), 
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166 and was routinely greater than 99%. All incubations were performed at 37o C in a 
167 humidified atmosphere containing 5% CO2 and 95% air.
168 Sample Preparation for microscopy
169 Primary microglia cells cultured from Cox8/EGFP mice were used for mitochondrial 
170 morphology analysis. Microglia cells were washed with PBS and plated on precision cover 
171 glasses thickness No. 1.5H (tol. ± 5 μm) in a 24-well plate, with 1x105 cells per well, and 
172 left to adhere overnight at 37°C in a cell culture incubator. Cells were fixed with 4% 
173 paraformaldehyde in culture media for 10 min and then mounted in ProLong Diamond 
174 antifade reagent (Life Technologies, Grand Island, NY) according to the manufacturer's 
175 instructions.
176 Live cell imaging
177 Primary microglia cells were seeded on MatTek (MatTek , Ashland, MA) glass bottom 
178 culture dishes. Following cell adherence, cells were exposed to DMSO alone (control) or 
179 LPS 100ng/ml for 24h or cells were pre-treated with Mdivi-1 (25 µM; Sigma, St. Louis, 
180 MO, USA) for 1h followed by LPS (100ng/ml) exposure for 24hrs. Cells were washed 
181 gently three times with warm PBS. Further anti-bleaching live cell visualization medium 
182 (DMEMgfp-2, Evrogen) was added to the cells 30 min before imaging. Images were 
183 acquired with a Zeiss LSM 880 Airyscan super-resolution system with live cell capabilities 
184 and fitted with a fast-ASmodule (Carl Zeiss, Oberkochen, Germany). Microscopes were 
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185 equipped with an environmental chamber that maintained 370C with humidified 5% CO2 
186 gas during imaging.
187 Super-Resolution Structured illumination microscopy (SR-SIM) 
188 Super-resolution structured illumination microscopy (SR-SIM) on a Zeiss ELYRA PS.1 
189 microscope (Carl Zeiss Microscopy, Germany) was used to yield a 2-fold improvement in 
190 all spatial directions  (Huang, Bates, & Zhuang, 2009) beyond the classical Abbe-Rayleigh 
191 limit. GFP was imaged using a Plan-Apochromat 100×/1.4 oil objective, an excitation 
192 wavelength of 488 nm and an emission wavelength range of 495-575 nm. The SR-SIM 
193 images were acquired as z-stacks with three angles and five phases in each plane and 
194 the z-step between planes was 3.30 nm. SR-SIM processing was performed using the 
195 Zeiss Zen software package. 3D rendering was done using Volocity 6 (Perkin-Elmer) and 
196 figures were compiled using Photoshop CC software (Adobe Systems, San Jose, CA).
197 Mitochondrial morphology analysis
198 Primary microglia were treated with LPS, Mdivi-1 or DMSO as described previously and 
199 mitochondria were categorised based on length: fragmented (<1 µm), tubular (1–3 µm) 
200 and elongated (>3 µm), as described previously (Jahani-Asl et al., 2011). Over 20 cells 
201 were analysed in Control, LPS-treated, LPS plus Mdivi-1 in three independent 
202 experiments. Volocity 6 was used for 3D rendering and to quantify mitochondrial length, 
203 volume and number.
Page 11 of 54
John Wiley & Sons, Inc.
GLIA
12
204 Measurement of Oxygen Consumption Rate (OCR) and Extracellular Acidification Rate 
205 (ECAR)
206 Real-time measurements of oxygen consumption rates, and extracellular acidification 
207 rates, a measure of lactate production, were performed on an XFe96 Seahorse 
208 extracellular flux analyser (Seahorse Biosciences, North Billerica, MA). The optimal 
209 seeding density and test compound concentrations were empirically determined prior to 
210 initiation of experiments. According to the methods described in the XFe96 Extracellular 
211 Flux Analyzer User Manual (Seahorse Bioscience), preliminary studies were run with 
212 Carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP) to identify the optimal 
213 number of cells required to observe a sufficient shift in OCR and ECAR.  Once the cell 
214 number was decided, we determined the optimal working concentrations for each of the 
215 stimulating compounds used in the mitochondrial function analysis (oligomycin, FCCP, 
216 and rotenone).  Cells were then plated into XFe96 cell culture plates (Seahorse 
217 Biosciences, North Billerica, MA) at a density of 10,000/well in 80 µl of DMEM (Sigma–
218 Aldrich, St Louis, MO, USA). Cells were allowed to adhere overnight in a 37°C incubator 
219 with 5% CO2. Following cell adherence, cells were exposed to a final concentration of 
220 Ultra-pure LPS 50 or 100ng/ml (Escherichia coli 055: B5, Biological Laboratories, 
221 Campbell, CA) or media alone (control) for 3, 6 or 24 h.  For mitochondrial fission blocking 
222 experiments, microglia cells were pre-treated with Mdivi-1 (25 µM) or DMSO for 1 h before 
223 LPS exposure. Media (80 µL) was removed followed by the addition of 200 µL XF base 
224 media (180 µl) supplemented with 10mM glucose, 5mM pyruvate, and 2mM glutamine for 
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225 OCR. For ECAR only 2mM glutamine was added following incubation in a non-CO2 
226 chamber for 1 h.
227 The day prior to the experiment, 200µl of XF calibration media was added to the XF 
228 sensor cartridges and kept in a non-CO2 incubator for 24h. XF sensor cartridges were 
229 loaded with test compounds and OCR/ECAR measured. OCR was measured by 
230 sequential injections of oligomycin (1μM final concentration, blocks ATP synthase to 
231 assess respiration required for ATP turnover), FCCP (carbonyl cyanide 4-
232 trifluoromethoxy-phenylhydrazone, 2μM final concentration, a proton ionophore 
233 uncoupler inducing maximal respiration), and rotenone plus antimycin A (1μM final 
234 concentration of each, which completely inhibits electron transport to measure non-
235 mitochondrial respiration).
236  ECAR was measured under glucose-starved microglia.  Basal glycolysis rate was 
237 determined by injecting glucose at a final concentration of 10mM. For estimating glycolytic 
238 capacity, oligomycin was injected at a final concentration of 5μM. Finally, 2-deoxyglucose 
239 (2-DG) was injected at a final concentration of 50mM to measure the non-glycolytic 
240 acidification. Each step had three cycles; each cycle consisted of 3 min mixing, 2 min 
241 incubation and 3 min measurement. All experiments were run in three replicates with 3-4 
242 sample per replicates. Cell counts were used to normalize OCR and ECAR.
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243 Multiplex cytokine assay
244 Bio-Plex Pro Mouse Cytokine Standard 23-Plex kit (Bio-Rad) was used to measure the 
245 concentrations of cytokines/chemokines in microglia-cultured media following the 
246 manufacturer’s protocol. Microglia conditioned media  was collected from microglia 
247 samples used in the OCR and ECAR experiments explained above. Samples were 
248 normalized to cell number (1x105; 1:10 in diluent buffer) and concentrations of IL-1α, IL-
249 1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL-17a, eotaxin, 
250 granulocyte colony-stimulating factor (G-CSF), granulocyte macrophage colony-
251 stimulating factor (GM-CSF), interferon-gamma (IFN-γ), KC/chemokine (C-X-C motif) 
252 ligand 1 (CXCL1), monocyte chemotactic protein-1 (MCP-1)/chemokine (C-C motif) 
253 ligand 2 (CCL2), macrophage inflammatory protein 1α (MIP-1α)/CCL3, MIP-1β/CCL4, 
254 RANTES, and TNF-α were simultaneously quantified on a Bio Plex 200 System (Bio-Rad, 
255 Sweden) and data presented as Log10 of cytokine concentrations (picograms per 
256 millilitre).
257 Succinate level measurement
258 Microglia cells were pre-treated with vehicle (DMSO), Mdivi-1 (25 µM; Sigma, St. Louis, 
259 MO, USA) for 1h or dimethyl malonate (DMM; 10mM; Sigma, St. Louis, MO, USA) for 3h 
260 before stimulation with LPS (100 ng/ml) for 24 h. Succinate Colorimetric Assay Kit 
261 (Sigma-Aldrich Inc., St Louis, MO, USA) was used to determine the succinate 
262 concentrations according to the manufacturer's instructions. Microglia cells (1× 105 cells 
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263 per well) were rapidly homogenized on ice in 100μL of ice-cold succinate assay buffer 
264 and centrifuged at 10,000×g for 5 min to remove insoluble material. Then, cell 
265 homogenates were added into a 96-well plate in duplicate wells and mixed with reaction 
266 mix provided in with the kit, which results in a colorimetric product proportional to the 
267 succinate present. The resultant mixtures were further incubated at 37°C for 20 min. The 
268 succinate concentration was determined by the standard curve using spectroscopy at 
269 450nm wavelength.
270 Measurement of mitochondrial ROS production by live cell imaging.
271 Mitochondrial superoxide generation was assessed in live cells using MitoSOX (Molecular 
272 Probes), a fluorogenic dye that is taken up by mitochondria, where it is readily oxidized 
273 by superoxide (O2−.). MitoSOX Red reagent is a novel fluorogenic dye specifically 
274 targeted to mitochondria in live cells. Oxidation of MitoSOX Red reagent produces red 
275 fluorescence by superoxide but not by other ROS or Reactive Nitrogen Species-
276 generating systems. Primary microglia cells were seeded on MatTek (MatTek , Ashland, 
277 MA) glass bottom culture dishes (1x105cells/dish) and left to adhere overnight. Following 
278 treatments described above, live microglia were incubated with 5µM MitoSOX at 37oC for 
279 10 min. Cells were washed gently three times with warm PBS further anti-bleaching live 
280 cell visualization medium (DMEMgfp-2) was added to the cells 30 min before imaging. 
281 Airyscan super-resolution microscopy on a LSM 880 (Carl Zeiss Microscopy, Germany) 
282 with an onboard incubator at 37oC was used to acquire images using a 63× oil objective, 
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283 an excitation wavelength of 488nm. Airyscan-processing was done using the Zeiss Zen 
284 software package. MitoSox fluorescence was quantified using Volocity 6. 
285 Measurement of the mitochondrial membrane potential by live cell imaging.
286 JC-1 (Molecular Probes) is a cationic dye that exhibits mitochondrial membrane potential-
287 dependent accumulation in mitochondria, indicated by a fluorescence emission shift from 
288 green (~525 nm) to red (~590 nm). Mitochondrial depolarization is indicated by a 
289 decrease in the red to green fluorescence intensity ratio. The potential sensitive color shift 
290 is due to concentration dependent formation of red fluorescent aggregates. Primary 
291 microglia cells were seeded, incubated and treated as above. Following LPS exposure, 
292 the media  was removed cells were incubated with JC-1 (2μM final concentration) and 
293 incubated at 37°C, 5% CO2 for 20 min. Cells were washed gently three times with warm 
294 PBS and further anti-bleaching live cell visualization medium (DMEMgfp-2) was added to 
295 the cells 30 min before imaging. Images were scanned using an oil immersion, 63×, and 
296 1.3 NA objective. Samples were excited at wavelength of 488nm and emission 
297 wavelength of 547 and 617 nm. The confocal pinhole aperture was set to 50, and the 
298 voltage to the photomultiplier tubes of each channel was maintained at equal values. 
299 Illumination was limited to periods of image acquisition.  Images were exactly in phase 
300 and represented the amount of monomeric and J-aggregate JC-1 fluorescence.
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301 Effect of Midivi-1 in an in vivo model of inflammation-mediated damage to the preterm 
302 brain
303 We employed a well characterized paradigm of systemic inflammation driven 
304 neuroinflammation (Favrais et al., 2011; Krishnan et al., 2017; Van Steenwinckel et al., 
305 2018), which is known to have effects on brain development and behavior consistent with 
306 those reported in infants and children born preterm(Ball et al., 2017; Raju, Buist, Blaisdell, 
307 Moxey-Mims, & Saigal, 2017) . Experimental protocols were approved by the institutional 
308 guidelines of the Institute National de la Santé et de la Recherche Scientifique (Inserm) 
309 France. The treatments was carried out as per previously described in full(Favrais et al., 
310 2011), with a shortened protocol described below. Assessment of gene expression were 
311 made only in male animals as female animals are not injured in this paradigm, mimicking 
312 the male predisposition to injury observed in male preterm born infants(Peacock, 
313 Marston, Marlow, Calvert, & Greenough, 2012). Briefly, mice received twice a day from 
314 P1 to P2 and once on P3 a 5-μl intra-peritoneal injection of 10 μg/kg/injection recombinant 
315 mouse IL-1β in phosphate buffered saline (PBS; R&D Systems, Minneapolis, MN) or PBS 
316 alone or P1–P3 pups were co-injected with IL-1β and 3 mg/kg/injection of Mdivi-1 (IP, 
317 5ul).
318 Isolation and ex vivo microglia and gene expression analysis
319 At P3,  brains were collected for cell dissociation and CD11B+ cell separation using a 
320 magnetic coupled antibody anti-CD11B (Miltenyi, MACS Technology) as previously 
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321 described in detail (Krishnan et al., 2017; Schang et al., 2014; Shiow et al., 2017). 
322 Microglia are the predominant CD11B cell in this model of injury by more than 100 fold 
323 compared to populations of either macrophage or neurtrophil (Krishnan et al., 2017).  
324 Total RNA was extracted from the CD11B+ microglia cells with the RNeasy mini kit 
325 (Qiagen, France), RNA quality and concentration were assessed by spectrophotometry 
326 (NanodropTM, Thermofisher Scientific, MA, USA). Reverse transcription was achieve 
327 with the iScriptTM cDNA synthesis kit (Bio-Rad, France) and RT-qPCR was performed in 
328 triplicate for each sample using SYBR Green Super- mix (Bio-Rad) as previously 
329 described (Chhor et al., 2013). Primers were designed using Primer3 plus software (See 
330 sequences in Sup. Table 1). Specific mRNA levels were calculated after normalization to 
331 Rpl13a mRNA (reference gene) based on previous reference gene suitability testing. The 
332 data are presented as relative mRNA units with respect to the control group (expressed 
333 as fold over control value). 
334 Statistics
335 All statistics are reported as mean ± SEM, performed using GraphPad Prism 7.0 
336 (GraphPad Software). Significance scores are * for p < 0.05, ** for p < 0.01, *** for p < 
337 0.001 and **** p<0.0001.
338
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339 Results
340 LPS exposure induces excessive mitochondrial fragmentation in microglial cells. 
341 Mitochondrial morphology was examined in primary microglia cells cultured from Cox8-
342 EGFP mice exposed to 50 or 100ng/mL LPS using 3D SR-SIM microscopy. The number 
343 of fragmented mitochondria was significantly increased in microglia cells stimulated with 
344 100ng/ml LPS for 24h (Fig 1c), and elongated and tubular mitochondria were decreased 
345 compared with untreated controls (Fig 1g). These findings are in line with previous studies 
346 in BV2 cells (Park et al., 2013) and primary microglia but with a higher dose of LPS 
347 (1ug/ml) (Katoh et al., 2017). There was no change in the morphology of cells stimulated 
348 with 50ng/ml LPS for 24h (Fig 1b,g).
349 LPS induces a switch from oxidative phosphorylation (OXPHOS) to glycolysis (metabolic 
350 reprogramming) in microglia cells.
351 Oxygen consumption rates (OCR) and extracellular acidification rates (ECAR) was 
352 measured in real time as measures of mitochondrial respiration and glycolysis for 50ng/ml 
353 LPS (fig 2a-c & i-k) and 100ng/LPS (Fig. 2o-q & w-y) respectively (Wu et al., 2007) with 
354 the Seahorse XFe96. Basal OCR and ATP-linked OCR was significantly increased in 
355 microglia cells following exposure to 50ng/ml LPS for 6-24h compared to controls (Fig.2d-
356 e). FCCP-induced maximal OCR and spare respiratory capacity (SRC) decreased 
357 whereas leak-driven OCR significantly increased with exposure to 50ng/mL of LPS (Fig. 
358 2f-h). The ECAR parameters (glycolysis, glycolytic capacity and glycolytic reserve) were 
Page 19 of 54
John Wiley & Sons, Inc.
GLIA
20
359 increased following exposure to 50ng/ml LPS for 6-24hrs compared to controls (Fig. 2l-
360 n). These results show that a moderate dose of LPS increases both OCR and glycolysis. 
361 Exposure to 100ng/mL of LPS for 6h resulted in an increase in basal OCR, ATP-linked 
362 OCR and leak-linked OCR compared to controls (Fig. 2r-s). In contrast, there was a 
363 significant decrease in basal OCR and ATP linked OCR at 24h after 100ng/mL LPS  (Fig. 
364 2r,s,u). FCCP-induced maximal OCR and SRC significantly decreased at 24h 100ng/mL 
365 LPS (Fig. 2t-u). Glycolytic parameters increased with 100ng/ml LPS exposure for 3-24h 
366 compared with controls (Fig.2w-y). The overall decrease in OCR and increase in ECAR 
367 parameters with 100ng/ml LPS for 24h indicates a metabolic switch from OXPHOS to 
368 glycolysis.
369 Mdivi-1 treatment blocks LPS-induced mitochondrial fragmentation and ROS production.
370 Many conserved GTPase proteins are involved in mitochondrial fusion and fission 
371 dynamics such as mitofusins (MFN1 and MFN2) and dominant optic atrophy 1 (OPA1) 
372 are needed for the fusion of mitochondrial outer and inner membranes (Song, Ghochani, 
373 McCaffery, Frey, & Chan, 2009). Dynamin-related protein 1 (DRP1) and mitochondrial 
374 Fission 1 protein (FIS1) are the main mitochondrial fission mediators (Frezza et al., 2006). 
375 We used the mitochondrial fission inhibitor Mdivi-1 (Ruiz, Alberdi, & Matute, 2018) as the 
376 high (100 ng/ml)  dose of LPS induced an increase in fragmented mitochondria (Fig. 3b). 
377 We examined the effect of pharmacologically blocking mitochondrial fission in LPS-
378 exposed microglia cells cultured from Cox8/EGFP mice by pre-treatment with 25 µM 
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379 Mdivi-1 for 1 h followed by incubation with LPS (100 ng/ml) for 24h. Results revealed that 
380 LPS-induced excessive mitochondrial fragmentation was significantly inhibited by Mdivi-
381 1 pre-treatment and normalized mitochondrial morphology (Fig. 3c). Mdivi-1 treatment 
382 before LPS exposure reduced the number of fragmented mitochondria and increased the 
383 number of tubular and elongated mitochondria to control levels (Fig. 3d) .
384 Mdivi-1 treatment normalized oxygen consumption and extracellular acidification rate in 
385 the microglia cells. 
386 Since Mdivi-1 restored mitochondrial morphology, we interrogated its effect on cellular 
387 respiration and ECAR-dependent glycolysis and glycolytic capacity (Fig. 4a, b, h, i).  
388 Mdivi-1 pre-treatment in cells exposed to LPS (100ng/ml for 6h) exhibited a decrease in 
389 the level of basal respiration and ATP-linked OCR to control levels compared to LPS 
390 treated cells (Fig. 4c-d). Conversely, Mdivi-1 treatment in cells exposed to 100ng LPS for 
391 24h led to an increase in basal and ATP-linked OCR compared to non-treated LPS 
392 exposed cells (Fig. 4c-d). Mdivi-1 treatment also increased FCCP-induced maximal OCR 
393 at 24h and leak-driven OCR compared to LPS exposed cells at both time points (Fig. 4e-
394 f). Administration of Mdivi-1 in combination with LPS normalized the spare respiratory 
395 capacity (Fig. 4g).  ECAR measurements showed that glycolysis and glycolytic capacity 
396 was significantly reduced to control levels in Mdivi-1 treated cells at 6 and 24h 100ng/ml 
397 LPS exposure (Fig.4h-k) compared to LPS exposed cells.
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398 Mdivi-1 reduces the LPS induced release of cytokines and chemokines.
399 To show how LPS activation was inducing an inflammatory reaction in the primary 
400 microglia and to test whether this was effected by Mdivi-1 we measured cytokine and 
401 chemokine response in microglia conditioned media after treatment with of LPS and or 
402 Mdivi-1 (supporting information Fig. S1 and S2). As expected both doses, of LPS led to 
403 a significant up-regulation of essentially all cytokines and chemokines compared to 
404 controls. In general there was much higher cytokine production in microglia exposed to 
405 100ng-24h LPS conditioned media compared to 50ng-24hr LPS. We next determined if 
406 blockage of mitochondrial fission also modulated LPS-induced expression of cytokine and 
407 chemokine mediators. Mdivi-1 significantly reduced the pro-inflammatory cytokines (IL-
408 1α, IL-6, TNF-α, IL-12(p40)), chemokines (G-CSF, CCL5, RANTES) and anti-
409 inflammatory cytokines (IL-10, IL-13) and the chemokines (monocyte chemotactic protein 
410 1 (MCP-1 β), in response to 100ng/ml of LPS for 24h.  The LPS-induced production of IL-
411 2, IL-5 and MIP1 α were not significantly reduced by Mdivi-1 (Fig.5).
412 Mdivi-1 suppresses LPS induced succinate production.
413 Succinate is a well-established pro-inflammatory metabolite that is known to accumulate 
414 during LPS induced macrophage activation (Mills et al., 2016) but the role of succinate 
415 during microglia activation needs further investigation. We found that LPS (100ng/ml) 
416 resulted in a significant increase of succinate (Fig.6a) accompanying the expression of 
417 pro/anti-inflammatory cytokines and chemokines.  Mdivi-1 pretreatment (Fig 6a) or 
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418 blocking succinate production by succinate dehydrogenase inhibitor (DMM,10mM) (Fig. 
419 6b) normalized succinate production. These results were further strengthened by the fact 
420 that  treatment with DMM or scavenging ROS production with NAC (10mM, 30 min) 
421 recapitulated the effects of Mdivi-1 (Fig.5) by reducing pro/anti-inflammatory cytokines 
422 and chemokine release (Supplementary figure S3). Excessive fission results in 
423 fragmented mitochondria and causes a metabolic shift in microglia (Khacho et al., 2014) 
424 from OCR to ECAR. This may result in increased succinate production which in turn acts 
425 as a feedback loop to amplify aberrant mitochondrial fission (Lu et al., 2018).
426 Inhibition of mitochondria fission by Mdivi-1 suppresses mitochondrial ROS production.
427 Mitochondrial ROS plays an important role in LPS-induced immune responses (Park et 
428 al., 2015). In order to examine the role of ROS production after LPS stimulation, 
429 mitochondrial ROS (mtROS) was measured with MitoSOX, a mitochondrial superoxide 
430 indicator. The fluorescence intensity of MitoSOX increased 24h after the LPS stimulation 
431 (100ng/ml, 24h) (Fig. 7). Treatment with Mdivi-1 (25 µM, 1h) before LPS exposure 
432 abolished the increase in MitoSOX fluorescence intensity observed 2h after the LPS 
433 stimulation. These results indirectly show that that mitochondrial fission (induced by TLR4 
434 stimulation) increases ROS production as shown in this study and others (Katoh et al., 
435 2017; Park et al., 2013).
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436 Mdivi-1 treatment attenuated LPS induced increase of mitochondrial membrane 
437 potential
438 Our data suggest that after LPS (100ng/ml) exposure for 24h microglia mainly depended 
439 on glycolysis for energy production. Therefore, we investigated the mitochondrial 
440 membrane potential using the mitochondrial membrane potential probe JC-1 in these 
441 conditions. We found that there was a consequent elevation of mitochondrial membrane 
442 potential and treatment with Mdivi-1 significantly reduced mitochondrial membrane 
443 potential (525/565 nm) ratio compared to LPS treated group (Fig. 8).
444 Mdivi-1 treatment attenuated microglial activation in a mouse paradigm of 
445 neuroinflammation. 
446 Based on our working hypothesis that Mdivi-1 can reduce the inflammatory reaction of 
447 microglia, we sought to investigate the potential for Mdivi-1 to reduce the activation of 
448 microglia in vivo (Favrais et al., 2011; Krishnan et al., 2017). We isolated microglia from 
449 the brains of animals at P3 following induction of systemically driven neuroinflammation 
450 and con-current treatment with Mdivi-1 from P1-P3. We analyzed the isolated microglia 
451 for gene expression of markers associated with functional phenotypes including cytotoxic 
452 (Nos2, Ptgs2, Cd32), repair and regeneration (Arg1, Lga3, Igf1), and immunomodulatory 
453 (Il1ra, Il4a, Socs3) phenotypes. Exposure to neuroinflammatory-stimuli affected the gene 
454 expression as expected (Krishnan et al., 2017), with increased expression of all of the 
455 genes except for the gene for IGF1, which was decreased. IGF1 is a pleotropic growth 
Page 24 of 54
John Wiley & Sons, Inc.
GLIA
25
456 factor necessary for myelonogenesis and known to be decreased by pro-inflammatory 
457 microglial activation (Wlodarczyk et al., 2017). Mdivi-1 treatment normalized to control 
458 (PBS) levels the expression of genes associated with  cytotoxicity and 
459 immunomodulation, but had no effect on IGF1 gene expression, and only partly recovered 
460 Galectin-3 gene expression (Lgal3), indicating that exposure to Mdivi-1, which inhibits 
461 mitochondrial fragmentation, modulates the microglial inflammatory response also in vivo 
462 (Fig. 9). 
463 Discussion
464 This study strengthens our knowledge of the links between mitochondrial architecture, 
465 inflammation and energy metabolism in microglial cells. We have shown that activation 
466 of microglia to a pro-inflammatory activation state increased mitochondrial fragmentation, 
467 which was accompanied by a reduction in oxidative phosphorylation and an increase in 
468 glycolysis, which was dose and time dependent. Pre-treatment with the putative 
469 mitochondrial division inhibitor, Mdivi-1, normalised LPS-induced mitochondrial 
470 fragmentation, normalised the cellular respiration and glycolysis to control levels. Mdivi-1 
471 greatly reduced LPS-induced cytokine production normalized LPS-induced ROS 
472 production and mitochondrial membrane potential. 
473 Neuroinflammation includes complex changes in microglial phenotypes, mediated by 
474 gene expression changes leading to the production of cytokines and chemokines and 
475 production of ROS. Altogether this triggers oxidative and nitrosative stress in the brain 
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476 (Bolouri et al., 2014; Hellström Erkenstam et al., 2016). We observed as expected that 
477 LPS-activated microglia produced a plethora of chemokines and cytokines and ROS. In 
478 this pro-inflammatory scenario, suppression of LPS-induced mitochondrial ROS plays a 
479 role in modulating the production of pro-inflammatory mediators by preventing MAPK and 
480 NF-κB activation suggesting a potential therapy for inflammation-associated degenerative 
481 neurological diseases (Park et al., 2015).
482 To understand LPS-induced changes in mitochondrial structure, we used high resolution 
483 3D ELYRA-SIM (Shim et al., 2012) to quantify mitochondrial morphology which revealed 
484 that high dose LPS for 24h increased fragmentation. A low dose of LPS caused an initial 
485 increase in OCR which was not accompanied by any change in mitochondrial 
486 morphology. However, a higher dose of LPS induced a decrease of OCR and a further 
487 increase of ECAR which triggered mitochondrial fission. Fragmented mitochondria 
488 constitute the preferred morphological state when respiratory activity is low (Westermann, 
489 2012). A high or moderate dose of LPS caused a decrease in respiration and cells 
490 became dependent on glycolysis favoring excessive fragmentation. The molecular 
491 mechanisms behind this response is not known but it has been proposed that the energy 
492 depletion elicits mitochondrial fragmentation and subsequent mitophagy (Youle & van der 
493 Bliek, 2012). Increased mitochondrial fragmentation due to excessive fission can 
494 exacerbate the inflammatory response of microglia (Ho et al., 2018) through modulation 
495 of DRP1 de-phosphorylation and elimination of ROS (Park et al., 2016).  We chose to use 
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496 Mdivi-1 a mitochondrial division inhibitor to study microglial metabolism as it related to 
497 mitochondrial morphology as  previous studies revealed that LPS exposure in microglia 
498 cells leads to activation of mitochondrial fission protein DRP1 (Katoh et al., 2017; Park et 
499 al., 2013).
500 Mdivi-1 is a widely accepted DRP-1 mediated mitochondrial fission inhibitor used in many 
501 studies (Baek et al., 2017; Peiris-Pagès, Bonuccelli, Sotgia, & Lisanti, 2018; So, Hsing, 
502 Liang, & Wu, 2012; Xie et al., 2013) . Our data supports the assertion that changes in 
503 mitochondrial dynamics may be needed for the expression of inflammatory mediators in 
504 activated microglia cells. Mdivi-1 has previously been shown to attenuate LPS-induced 
505 ROS and proinflammatory mediator production in a BV-2 microglial cell line (Park et al., 
506 2013) with a very high dose of 1ug/ml.  BV2 cells are similar to primary microglia (Henn 
507 et al., 2009), but they contain oncogenes that render them phenotypically different with 
508 regard to e.g. proliferation and adhesion (Horvath, Nutile-McMenemy, Alkaitis, & Deleo, 
509 2008). Our findings not only show that pre-treatment with Mdivi-1 reduced LPS-induced 
510 mitochondrial fragmentation and expression of pro-inflammatory mediators, but also 
511 normalized mitochondrial function in microglia. These data support the suggestion that 
512 increasing the fusion/fission ratio reduces the extent of neuroinflammation (Kim, Lee, 
513 Park, Kim, & Roh, 2016). To further support the potential validity of targeting fission as a 
514 therapeutic strategy, we tested the ability of Mdivi-1 to modify microglial activity in vivo. 
515 We used a paradigm of systemically driven neuroinflammation, wherein an IP injection of 
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516 the inflammatory agent interleukin-1β induces a highly complex neuroinflammatory 
517 reaction involving microglia (Krishnan et al., 2017; Van Steenwinckel et al., 2018). 
518 Supporting our in vitro data mdivi-1 was able to reduce the expression of genes 
519 associated with classically pro-inflammatory genes, and the anti-inflammatory activation 
520 state, which is associated with the in vivo inflammatory reaction.  
521 Previous work with BV2 demonstrated that LPS causes an inhibition of OXPHOS 
522 (Voloboueva, Emery, Sun, & Giffard, 2013). However, this study used a very high dose 
523 of LPS (1µg/ml) which is shown to elicit mitochondrial toxicity (Ahn et al., 2012). We 
524 demonstrate for the first time that a low or moderate dose of LPS (50ng/ml) results in an 
525 increase of ATP linked OCR and basal respiration in support of another study in skeletal 
526 muscle cells where they used a very low dose of LPS in isolated mitochondria (Frisard et 
527 al., 2015). High dose of LPS (100ng/ml) caused a decrease in FCCP induced maximal 
528 respiration and an increase in leak-driven respiration. A depletion of spare respiratory 
529 capacity was found at 6 and 24h following LPS exposure. However, we have noted no 
530 significant difference in cell viability or death after LPS.
531 OCR exhibited a biphasic response characterized initially by an increase of OCR in 
532 response to low LPS and then a marked drop of OCR after moderate to high doses of 
533 LPS whereas ECAR increased in proportion to the dose of LPS. We interpret the initial 
534 increase of OCR as a means to match an increased demand of ATP. However, as the 
535 pro-inflammatory stimulus becomes stronger it appears favourable to shift from 
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536 mitochondrial respiration to aerobic glycolysis (Warburg effect) in order to promote more 
537 rapid ATP production (Kelly & O'Neill, 2015; Orihuela et al., 2016) and synthesis of 
538 inflammatory mediators such as cytokines/chemokines and ROS (Kelly & O'Neill, 2015).  
539 We believe the Warburg effect is an important concept for understanding metabolic 
540 changes occurring during microglial activation. It is shown that also activation of 
541 macrophages or dendritic cells (DCs)  with LPS, induces a metabolic switch from 
542 OXPHOS to glycolysis (Krawczyk et al., 2010).  Metabolic shift may be facilitated by 
543 increased mitochondrial fission and/or reduced fusion mediated by DRP1 activation 
544 (Baker, Maitra, Geng, & Li, 2014). However, as glycolysis is less efficient at producing 
545 ATP than OXPHOS, this metabolic reorientation cannot solely be to meet energy 
546 demands. Glycolysis may also facilitate in cytokine production by producing intermediate 
547 metabolites (Mills et al., 2016). A previous study found that glycolysis was required to 
548 produce optimal IFN-γ during T cell activation and is translationally regulated by the 
549 binding of the glycolysis enzyme GAPDH to IFN-γ mRNA (Chang et al., 2013). 
550 Our results in microglia add to what has already been shown in DCs and macrophages  
551 (Williams & O’Neill, 2018),  specifically that pro-inflammatory activation resulted in 
552 increased succinate accumulation.  In dendritic cells (DCs) and macrophages this 
553 succinate accumulation was related to an altered Krebs cycle  and this was was 
554 normalized by Mdivi-1. Aberrant mitochondrial fission alters the Krebs cycle, by interfering 
555 with the processes after citrate and after succinate (Jha et al., 2015) by reducing of 
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556 cytochrome c oxidase and succinate dehydrogenase activity (B. Zhang et al., 2013). 
557 Impaired succinate dehydrogenase activity results in succinate accumulation due to 
558 impaired succinate to fumarate conversion (Mills et al., 2016). Accumulated succinate 
559 drives reverse electron transport (RET) to generate excessive mitochondrial ROS 
560 production (Chouchani et al., 2014; Niatsetskaya et al., 2012). Our data support this link 
561 between accumulation of succinate and ROS production, which was prevented by Mdivi-
562 1.
563 LPS induced an increase in membrane potential and proton with an increase in 
564 membrane potential. Proton leak is partly mediated by uncoupling proteins (UCPs) 
565 present in the mitochondrial inner membrane (Hass & Barnstable, 2016; Krauss, Zhang, 
566 & Lowell, 2005). It is shown that in primary microglia LPS induces an increase in UCP2 
567 levels and membrane potential. UCP2‐silenced microglia stimulated with LPS show a 
568 decrease in membrane potential (De Simone et al., 2015). In macrophages LPS 
569 stimulation repurpose their mitochondria from ATP production to succinate-dependent 
570 ROS generation, with glycolysis taking on the role of ATP generation. In this case 
571 mitochondria sustain a high membrane potential because protons generated by the 
572 electron transport chain to make ATP are no longer being consumed by mitochondrial 
573 ATP synthase (Mills et al., 2016). Macrophages can also reorganize their respiratory 
574 chain in response to a bacterial infection, decreasing  Complex I levels and increasing 
575 the activity of Complex II (Garaude et al., 2016). These changes boost production of pro-
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576 inflammatory cytokines such as interleukin 1β (IL-1β) and IL-10. Our data support these 
577 findings as normalizing mitochondrial membrane potential and ROS production with 
578 Mdivi-1 abolished pro- and anti-inflammatory cytokine and chemokine release. 
579 Aberrant activation of microglial affects neurodegenerative processes through various 
580 neurotoxic cascades. We have shown that pro-inflammatory microglial activation alters 
581 cellular bioenergetics by inducing mitochondrial dysfunction and promoting a switch to 
582 glycolysis, supported by excessive mitochondrial fragmentation and increased cytokine 
583 output. This is likely an adaptive mechanism as the transition of sensing and surveying 
584 microglia into an activated state is likely to be accompanied by significantly increased 
585 energy consumption. Preventing excessive mitochondrial fission in microglial cells 
586 stimulated with LPS using a fission inhibitor Mdivi-1 normalizes mitochondrial respiration 
587 and glycolysis and attenuates the release of cytokines/chemokines. These lines of  in 
588 vitro morphological and functional data and the in vivo data suggest that regulating 
589 mitochondrial dynamics may be a useful therapeutic modality for preventing neurological 
590 disorders caused by aberrant microglia activation.
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 Fig:1 LPS induces dose-dependent mitochondrial fragmentation. Super-resolution microscopy reveals 
excessive mitochondrial fragmentation (a) Control (b) 50ng/ml LPS exposure for 24hrs (c) 100ng/ml LPS 
exposure for 24hrs (d-f) shows a higher magnification of the image in the white square in the upper panel. 
(g) Graphs showing results from an analysis of mitochondria morphology in primary microglia cells treated 
with LPS for 24h. The data are for at least 12 cells per condition in three independent experiments. Bar 
graphs expressed as mean ± SEM. ***P ≤ 0.001; student-t test calculating the difference between control 
and LPS treated groups. 
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 Fig:2 LPS dependent metabolic shift. Low dose of LPS (50 ng/ml) induces an increase in mitochondrial 
respiration and glycolysis: 50ng/ml LPS treatment shows an increase in Basal OCR, ATP linked OCR (d-e) 
whereas FCCP linked maximal OCR (f) and spare respiratory capacity (g) decreased from 3- 24hrs. Leak-
driven OCR was also increased from 6-24hrs. Glycolytic parameters, based on ECAR, tended to increase 
from 3-24hrs (i-n). Whereas a high dose (100ng/ml) of LPS induces a time dependent metabolic shift. 
100ng/ml LPS treatment for 6h shows an increase in Basal OCR, ATP linked OCR, while LPS treatment for 
24h resulted in a decrease of Basal and ATP linked OCR (r-s). FCCP linked maximal OCR (t) and spare 
respiratory capacity (u) decreased from 6- 24hrs. Leak driven OCR was increased at 6 hrs (v). OCR and 
ECAR measured for 3,6 and 24hrs are expressed in bar graph format as the mean ± SEM n=9. *P ≤ 0.05; 
**P ≤ 0.01; ***P ≤ 0.001 student t test calculating the difference between control and LPS treated groups. 
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 Fig.3 Pharmacologic blockade of DRP1 by Mdivi-1 re-established mitochondrial morphology. Mdivi-1 pre-
treatment (25µm) for 1hr followed by LPS (100ng/ml) exposure for 24h resulted in a decrease of 
fragmented mitochondria and an increase in tubular and elongated mitochondria (d).  A-Control cells treated 
with vehicle (DMSO), B- LPS (100ng/ml) exposure for 24h, C- LPS (100ng/ml)+ Mdivi-1. Bar graphs 
expressed as mean ± SEM. The data are for at least 12 cells per condition in three independent 
experiments. **P ≤ 0.01; ***P ≤ 0.001; student-t test calculating the difference between LPS and 
LPS+Mdivi-1 groups. 
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 Fig.4 Mdivi-1 treatment reversed the metabolic shift. Inhibition of DRP1 by Mdivi-1 resulted in reduced basal 
OCR and ATP-linked OCR at 6h whereas Mdivi-1 increased basal OCR and ATP-linked OCR at 24h compared 
to 100ng/ml LPS exposure (c-d). LPS induced reduction in FCCP-induced maximal respiration and Leak-
driven OCR at 24hr, which was normalized by Mdivi-1(e-f). The LPS-evoked drop in SRC was prevented by 
Mdivi-1 (g). Midivi-1 normalized LPS-induced increased ECAR dependent glycolysis and glycolytic capacity (j-
h). OCR and ECAR measured for 3, 6 and 24hrs are expressed in bar graph format as the mean ± SEM n=6-
9. ***P ≤ 0.001;, student-t test calculating the difference between LPS and LPS+Mdivi-1 treated groups. 
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 Fig.5 Mdivi-1 treatment abolished LPS induced exaggerated pro/anti cytokine and chemokine response. 
Microglia cells were pre-treated with Mdivi-1 (25µM) for one hour followed by LPS (100ng/ml) for 24h, MCM 
were collected and analysed by 23-plex cytokine assay. Heat maps show cytokine concentration (pg/ml). KC 
= keratinocyte chemoattractant. n=8 *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001;, student-t test calculating the 
difference between LPS and LPS+Mdivi-1 treated groups. 
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 Fig.6 (A) Mdivi-1 normalized LPS induced succinate upregulation. Microglia cell homogenates of cells were 
analysed by succinate colorimetric assay. Microglia cells were pre-treated with Mdivi-1 (25uM; 1h) followed 
by LPS exposure of 100ng LPS for 24h resulted in significant downregulation of LPS induced succinate 
upregulation. Bar graph expressed as the mean ± SEM n=8. *P ≤ 0.05; student-t test calculating the 
difference between LPS and LPS+Mdivi-1 treated groups. (B) Succinate dehydrogenase inhibitor 
recapitulated the effects of Mdivi-1. Pre-treatment with dimethyl malonate (DMM, 10mM; 3h) prior to LPS 
exposure attenuated succinate accumulation. Bar graph format as the mean ± SEM n=9. *P ≤ 0.05, Turkeys 
post-hoc test using One-Way Anova revealed difference between control, control + DMM, LPS and LPS+DMM 
treated groups. 
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 Fig.7 Mdivi-1 treatment abolished LPS induced mitochondrial ROS production. (A) Control (B) 100ng/ml LPS 
exposure for 24hrs (C) LPS+Mdivi-1 (D) Graphs showing results from an analysis of mitosox fluorescence by 
live cell airyscan microscopy. The data are for at least 12 cells per condition in three independent 
experiments. Bar graphs expressed as mean ± SEM. **P ≤ 0.01, student-t test calculating the difference 
between control LPS and Mdivi-1 treated groups. 
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 Fig.8 Mdivi-1 treatment attenuated LPS induced increase of mitochondrial membrane potential: (a-c) Control 
(d-e) 100ng/ml LPS exposure for 24hrs (g-h) LPS+Mdivi-1. Graphs showing results from an analysis of JC1 
fluorescence 525/565 nm by live cell airyscan microscopy. The data are for at least 6 cells per condition in 
three independent experiments. Bar graphs expressed as mean ± SEM. **P ≤ 0.01, ***P ≤ 0.001, student-
t test. 
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 Fig.9 (A) Schematic representation of the testing of the effects of Mdivi-1 on neuroinflammation induced 
microglial gene expression in vivo. (B) Mdivi-1 prevented many of the neuroinflammation (IL-1β-induced) 
alterations in gene expression. Relative gene expression of Ptsg2, Cd32, Nos2, Lgal3, Igf1, Arg1, Il4ra, Il1rn 
and Socs3 were assessed by qRT-PCR from MACS isolated CD11b+ microglia from P3 mice. Protein names 
for the genes are shown in brackets on the panels. The legend indicates that the first bar (blue) is the 
control (PBS injected group), the middle bar (red) is the neuroinflammatory challenge group, and that the 
right bar (green) is the group challenged with neuroinflammation but also treated with Mdivi-1. The dotted 
line highlights the gene expression in the control group.  Results are expressed as the mean ± SEM. There 
are 10-15 data points from three independent experiments per group. Data were analysed with a Kruskal–
Wallis ANOVA, P<0.001 with a Dunn’s test for comparison among groups: **p<0.01, *** p<0.001, **** 
p<0.0001. 
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 Fig. S1 and S2 (Supplementary) LPS induces exaggerated cytokine, chemokine following LPS exposure. The 
medium of microglial cells exposed with LPS 50 and 100ng/ml were sampled after 3,6 and 24h of LPS 
exposure and analyzed by 23-plex cytokine assay. Heat maps show the Log10 of cytokine concentration 
(pg/ml). n=8 KC = keratinocyte chemoattractant. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; student-t test 
calculating the difference between control and LPS treated groups. 
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 Fig.S3 (Supplementary) DMM or NAC attenuated LPS induces cytokine and chemokine production. Microglia 
cells were pre-treated with DMM (10mM, 3h) or NAC (10mM, 30 min) followed by LPS (100ng/ml) for 24hr, 
microglial culture medium was collected and analysed by 23-plex cytokine assay. Heat maps show cytokine 
concentration (pg/ml). KC = keratinocyte chemoattractant. n=8 *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001;, 
One-way anova and turkeys multiple test  calculating the difference between Control, LPS, LPS+Mdivi-1 and 
LPS+NAC treated groups. *- rep significant difference with respect to LPS and treatment groups. *- rep 
significant difference between treatment groups 
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Supplementary Table 1: Primer sequences, protein targets and NCBI references 
 
Gene Target protein and abbreviation Sense Anti-sense NCBI Reference 
Inos Inducible nitric oxide synthase (iNOS) CCC TTC AAT GGT TGG TAC 
ATG G 
ACA TTG ATC TCC GTG ACA 
GCC 
NM_010927.3 
CD32 Cluster of differentiation 32 (CD32) CTG GAA GAA GCT GCC AAA 
AC 
CCA ATG CCA AGG GAG ACT AA NM_010187.2 
Ptgs2 Cyclooxygenase-2 (Cox-2) TCA TTC ACC AGA CAG ATT 
GCT 
AAG CGT TTG CGG TAC TCA TT NM_011198.3 
Arg1 Arginase-1 (Arg1) TG AAG AAC CCA CGG TCT 
GT 
GCC AGA GAT GCT TCC AAC TG NM_007482.3 
Lgals3 Galectin-3 (Gal-3) GAT CAC AAT CAT GGG CAC 
AG 
ATT GAA GCG GGG GTT AAA GT NM_010705.3 
Igf1 Insulin like growth factor 1 (IGF-1) TGG ATG CTC TTC AGT TCG 
TG 
GCA ACA CTC ATC CAC AAT GC NM_010512.4 
Il1rn Interleukin 1 receptor antagonist (IL-1Rn) TTG TGC CAA GTC TGG AGA 
TG 
TTC TCA GAG CGG ATG AAG GT NM_031167.5 
Il4ra Interleukin 4 receptor alpha (IL-4Rα) GGA TAA GCA GAC CCG AAG 
C 
ACT CTG GAG AGA CTT GGT 
TGG 
NM_001008700.3 
Socs3 Suppressor of cytokines 3 (SOCS3) CGT TGA CAG TCT TCC GAC 
AA 
TAT TCT GGG GGC GAG AAG AT NM_007707.3 
 
 
 
Page 54 of 54
John Wiley & Sons, Inc.
GLIA
